EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Recent Progress on Nanomedicine‐Mediated Repolarization of Tumor‐Associated Macrophages for Cancer Immunotherapy

Jing‐Yang Zhang, Yun‐He Su, Xu Wang, Xueqing Yao, Jin‐Zhi Du

WIREs Nanomedicine and Nanobiotechnology · 2024-09 · 16 (5)

DOI: 10.1002/wnan.2001 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Tumor‐associated macrophages (TAMs) constitute the largest number of immune cells in the tumor microenvironment (TME). They play an essential role in promoting tumor progression and metastasis, which makes them a potential therapeutic target for cancer treatment. TAMs are usually divided into two categories: pro‐tumoral M2‐like TAMs and antitumoral M1 phenotypes at either extreme. The reprogramming of M2‐like TAMs toward a tumoricidal M1 phenotype is of particular interest for the restoration of antitumor immunity in cancer immunotherapy. Notably, nanomedicines have shown great potential for cancer therapy due to their unique structures and properties. This review will briefly describe the biological features and roles of TAMs in tumor, and then discuss recent advances in nanomedicine‐mediated repolarization of TAMs for cancer immunotherapy. Finally, perspectives on nanomedicine‐mediated repolarization of TAMs for effective cancer immunotherapy are also presented.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →